US$ 26.93
glp 1 adoption Obesity GLP-1 Market GLP-1 Receptor Agonist Market Forecast
Description
Growing private healthcare expenditure and increasing physician adoption of advanced metabolic therapies continue to support market expansion

doi: 10.1016/S0140-6736(06)69705-5 34 HolstJJ

The initial adjustment period ends

A 1.0 ml syringe handles maintenance doses in one injection at this concentration, with a second small draw for higher doses

It was cost prohibitive. That could soon change
Learn more about Wegovys uses and side effects
